Lv51
1090 积分 2023-08-02 加入
[Consensus on the management of liver injury associated with targeted drugs and immune checkpoint inhibitors for hepatocellular carcinoma ( version 2024)]
2小时前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study
2小时前
已完结
Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: A randomized, double-blind trial
1个月前
已完结
Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
Effect of recombinant Factor VIIa on outcome of acute variceal bleeding: an individual patient based meta-analysis of two controlled trials
1个月前
已完结
How to manage coagulopathies in critically ill patients
1个月前
已完结
Guideline No. 452: Diagnosis and Management of Intrahepatic Cholestasis of Pregnancy
4个月前
已完结
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
4个月前
已完结
Hepatorenal syndrome
4个月前
已完结
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
4个月前
已完结
皖公网安备34019202002308
